COMMUNIQUÉS West-GlobeNewswire

Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
09/09/2024
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic [...]
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
09/09/2024
SUNNYVALE, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology
09/09/2024
DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]
Terns Announces Proposed Public Offering
09/09/2024
FOSTER CITY, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Abivax presents first-half 2024 financial results
09/09/2024
Abivax presents first-half 2024 financial results Cash balance of EUR 222M at June 30, 2024; cash runway in to Q4 2025 PARIS, France, September 9, 2024, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX [...]
TriArm Therapeutics Appoints Douglas E. Williams, Ph.D., as Chief Executive Officer
09/09/2024
SAN MATEO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- TriArm Therapeutics (“TriArm” or the “Company”), a clinical-stage, next-generation cell therapy company leveraging its global presence and core non-viral platform to [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
09/09/2024
TAMPA, Fla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced the [...]
Recovery First Treatment Center Launches Evening Virtual Treatment Program in English and Spanish, Expanding Access to Care
09/09/2024
HOLLYWOOD, Fla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- As the nation recognizes National Recovery Month, Recovery First Treatment Center has launched a virtual evening Intensive Outpatient Program (IOP) to help more people [...]
ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer
09/09/2024
81.8% ORR by BICR and 63.6% confirmed ORR by BICR at the 240 mg dose; 46.2% confirmed ORR in CNS Metastases 90.9% (n = 20/22) of patients with confirmed responses remained on study with a median duration of response not [...]
Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
09/09/2024
Beamion LUNG-1, Phase Ib met its primary endpoint, demonstrating a meaningful objective response rate (ORR) of 66.7%, as assessed by blinded independent central review (BICR) 1 Preliminary activity in patients with [...]
Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
09/09/2024
Company announcement – No. 44 / 2024 Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Placebo-adjusted [...]
CorMedix Inc. Announces New Commercial Agreement
09/09/2024
BERKELEY HEIGHTS, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today [...]
World-renowned diabetes researcher joins Wendy Novak Diabetes Institute
09/09/2024
Norton Healthcare, Norton Children’s to become a hub for isolating high-quality human islet cells for diabetes research and transplant LOUISVILLE, Ky., Sept. 09, 2024 (GLOBE NEWSWIRE) -- An internationally known [...]
PetVivo Meets Growing Demand for Spryng™ with Appointment of Veterinary Surgeon, Kirsty Husby, as Senior Technical Services Veterinarian
09/09/2024
Expert Capablites of Senior Vet-Tech to Help Drive Greater Adoption of Spryng as Breakthrough Treatment of Osteoarthritis for Companiaon Animals MINNEAPOLIS, MN, & Annapolis Junction, MD, US, Sept. 09, 2024 (GLOBE [...]
Novo Nordisk A/S - share repurchase programme
09/09/2024
Bagsværd, Denmark, 9 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 [...]
ADvantage Therapeutics, Inc. Welcomes Dr. William A. Haseltine as Strategic Advisor to Drive Innovation in Alzheimer's Disease Research and Anti-aging Therapies such as Klotho Protein Supplementation to Extend Healthy Human Lifespan
09/09/2024
MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a leading clinical-stage biotechnology company dedicated to the advancement of innovative therapies for Alzheimer's disease, proudly announces the [...]
Novo Nordisk A/S - share repurchase programme
09/09/2024
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 9 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the [...]
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
09/09/2024
Early Pilot Study Data from Veteran Volunteers is Compelling - Part B JACKSON CENTER, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) today issued the following letter to its shareholders: We [...]
Scilex Holding Company to Present at the 26th Annual H.C. Wainwright Global Investment Conference
09/09/2024
PALO ALTO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

Pages